Advertisement
Advertisement
COCH
Envoy Medical, Inc. Class A Common Stock
6.50
USDSponsored
-0.16
-2.40%
Oct 29, 15:59 UTC -4
Closed
After-Market
6.50
0.00
+0.03%
Envoy Medical, Inc. Class A Common Stock (COCH) Earnings
COCH Earnings Reports
Positive Surprise Ratio
COCH beat 3 of 10 last estimates.
30%
Next Report
Date of Next Report
Nov 18, 2026
Estimate for Q3 26 (Revenue/ EPS)
$88.40K
/-$0.06
Implied change from Q2 26 (Revenue/ EPS)
+73.34%
/-14.29%
Implied change from Q3 25 (Revenue/ EPS)
+110.48%
/-82.35%
Envoy Medical, Inc. Class A Common Stock earnings per share and revenue
On Aug 10, 2026, COCH reported earnings of -0.07 USD per share (EPS) for Q2 26, beating the estimate of -0.08 USD, resulting in a 14.22% surprise. Revenue reached 51.00 thousand, compared to an expected 81.60 thousand, with a -37.50% difference. The market reacted with a +5.04% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 88.40 thousand USD, implying an decrease of -14.29% EPS, and increase of 73.34% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alphatec Holdings, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.09
Actual
$0.09
Surprise
-6.83%
Beta Bionics, Inc. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.53
Actual
-$0.52
Surprise
+2.73%
Integra LifeSciences Holdings
Report Date
Oct 21, 2026 For Q3 26
Estimate
$0.57
Actual
$0.59
Surprise
+3.04%
OrthoPediatrics Corp. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.21
Actual
-$0.23
Surprise
-4.88%
ClearPoint Neuro, Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.24
Surprise
+25.30%
Thermo Fisher Scientific, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$6.46
Actual
$6.68
Surprise
+3.29%
Intuitive Surgical Inc.
Report Date
Oct 20, 2026 For Q3 26
Estimate
$2.69
Actual
$3.00
Surprise
+11.29%
IQVIA Holdings Inc.
Report Date
Oct 27, 2026 For Q3 26
Estimate
$3.30
Actual
$3.34
Surprise
+0.97%
Glaukos Corporation
Report Date
Oct 28, 2026 For Q3 26
Estimate
-$0.09
Actual
$0.47
Surprise
+611.98%
Axogen, Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.14
Actual
$0.21
Surprise
+47.06%
FAQ
What were Envoy Medical, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Envoy Medical, Inc. Class A Common Stock reported EPS of -$0.07, beating estimates by 14.22%, and revenue of $51.00K, -37.5% below expectations.
How did the market react to Envoy Medical, Inc. Class A Common Stock's Q2 2026 earnings?
The stock price moved up 5.04%, changed from $0.67 before the earnings release to $0.70 the day after.
When is Envoy Medical, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Nov 18, 2026.
What are the forecasts for Envoy Medical, Inc. Class A Common Stock's next earnings report?
Based on 3
analysts, Envoy Medical, Inc. Class A Common Stock is expected to report EPS of -$0.06 and revenue of $88.40K for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.